Setback For Roche In Valcyte Patent Case As Indian Court Orders A Re-examination

MUMBAI - In a major setback to Swiss drug maker Roche, the Madras High Court has directed India's Controller General of Patents to re-examine the patent rights granted to anti-HIV drug Valcyte (valgancyclovir)